Abstract
Introduction: As suggested through several autopsy studies there is a high prevalence of latent prostate cancer in the population. A much smaller proportion of prostate cancer is detected because of clinical symptoms. This study was done to identify the rates of incidentally detected prostate cancer in patients undergoing surgical management of Benign Prostatic Hyperplasia (BPH) in our centre.
 
 Methods: A retrospective review was done on all transurethral resections of the prostate (TURP) cases from May 2014 to May 2015 at a single tertiary care institution. One hundred and three men, aged 40 to 88 year, underwent TURP and their specimens were sent for the histopathological analysis.
 
 Results: Five (4.85%) patients were diagnosed with the prostate cancer. All the five patients had Gleason score of seven or more. Two patients had moderately differentiated adenocarcinoma with Gleason score of seven. Three patients had poorly differentiated adenocarcinoma with Gleason score of eight or above. The Prostate cancer was seen only in the age group above 65 years but it was not statistically significant.
 
 Conclusion: Our series demonstrated that 4.85% of patients had latent prostate cancer. It occurs mainly in men above 65 years of age though this was not statistically significant.
Highlights
As suggested through several autopsy studies there is a high prevalence of latent prostate cancer in the population
The landmark study by Bill-Axelson et al in 2011, confirmed early prostatectomy was significantly associated with reduced mortality when compared with watchful waiting.[2]
This study reported that in men aged ≤65 years, the number needed to treat to avert one death was only four. These findings suggest that early prostate cancer diagnosis and management is critical in this younger population
Summary
As suggested through several autopsy studies there is a high prevalence of latent prostate cancer in the population. Conclusion: Our series demonstrated that 4.85% of patients had latent prostate cancer It occurs mainly in men above 65 years of age though this was not statistically significant. The landmark study by Bill-Axelson et al in 2011, confirmed early prostatectomy was significantly associated with reduced mortality when compared with watchful waiting.[2] At 23 year follow up, men aged ≤65 years experienced the greatest oncological benefit, with a reduction in overall mortality of 25.5% and a prostate cancer death reduction of 15.8% following prostatectomy.[3] this study reported that in men aged ≤65 years, the number needed to treat to avert one death was only four These findings suggest that early prostate cancer diagnosis and management is critical in this younger population
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
